Drugs / CDCA1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00633724 | May 2007 → Jun 2012 | non-small cell lung carcinoma | Fukushima Medical University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CDCA1 | “The fourth peptide used was derived from TTK protein kinase (TTK) or cell division associated 1 (CDCA1).” PMID 23578144 ↗ Apr 2013 |
| Known as | TTK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00633724 ↗ |